{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:29:21Z","timestamp":1791296961144,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T00:00:00Z","timestamp":1359590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunogenetics"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00251-013-0682-0","type":"journal-article","created":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T10:36:40Z","timestamp":1359542200000},"page":"333-343","source":"Crossref","is-referenced-by-count":17,"title":["KIR gene variability in cutaneous malignant melanoma: influence of KIR2D\/HLA-C pairings on disease susceptibility and prognosis"],"prefix":"10.1007","volume":"65","author":[{"given":"Jos\u00e9 A.","family":"Campillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Legaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Roc\u00edo","family":"L\u00f3pez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Bolar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Las Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Minguela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda R.","family":"Moya-Quiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Blanco-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helios","family":"Mart\u00ednez-Banaclocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Garc\u00eda-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Roc\u00edo","family":"\u00c1lvarez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Mart\u00ednez-Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,31]]},"reference":[{"key":"682_CR1","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.humimm.2010.06.019","volume":"71","author":"S Al Omar","year":"2010","unstructured":"Al Omar S, Middleton D, Marshall E, Porter D, Xinarianos G, Raji O, Field JK, Christmas SE (2010) Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors. Human Immunol 71:976\u2013981","journal-title":"Human Immunol"},{"key":"682_CR2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00262-004-0526-8","volume":"53","author":"A Anichini","year":"2004","unstructured":"Anichini A, Vegetti C, Mortarini R (2004) The paradox of T cell mediated antitumor immunity in spite of poor clinical outcome in human melanoma. Cancer Immunol Immunother 53:855\u2013864","journal-title":"Cancer Immunol Immunother"},{"key":"682_CR3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00251-012-0623-3","volume":"64","author":"S Aranda-Romo","year":"2012","unstructured":"Aranda-Romo S, Garc\u00eda-Sepulveda CA, Comas-Garc\u00eda A, Lovato-Salas F, Salgado-Bustamante M, G\u00f3mez-G\u00f3mez A, Noyola DE (2012) Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections. Immunogenetics 64:653\u2013662","journal-title":"Immunogenetics"},{"key":"682_CR4","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.4049\/jimmunol.160.11.5239","volume":"160","author":"AB Bakker","year":"1998","unstructured":"Bakker AB, Phillips JH, Figdor CG, Lanier LL (1998) Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, \u03b3\u03b4 T cells, and antigen-specific CTL. J Immunol 160:5239\u20135245","journal-title":"J Immunol"},{"key":"682_CR5","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sober AJ, Sondak VK (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199\u20136206","journal-title":"J Clin Oncol"},{"key":"682_CR6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.genom.7.080505.115726","volume":"7","author":"AA Bashirova","year":"2006","unstructured":"Bashirova AA, Martin MP, McVicar DW, Carrington M (2006) The killer immunoglobulin like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 7:277\u2013300","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"682_CR7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s00251-005-0065-2","volume":"57","author":"JA Campillo","year":"2006","unstructured":"Campillo JA, Mart\u00ednez-Escribano JA, Muro M, Moya-Quiles R, Mar\u00edn LA, Montes-Ares O, Guerra N, S\u00e1nchez-Pedre\u00f1o P, Fr\u00edas JF, Lozano JA, Garc\u00eda-Alonso AM, \u00c1lvarez-L\u00f3pez MR (2006a) HLA class I and class II frequencies in patients with cutaneous malignant melanoma from south-eastern Spain: the role of HLA-C in disease prognosis. Immunogenetics 57:926\u2013933","journal-title":"Immunogenetics"},{"key":"682_CR8","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1158\/1078-0432.CCR-06-0019","volume":"12","author":"JA Campillo","year":"2006","unstructured":"Campillo JA, Mart\u00ednez-Escribano JA, Moya-Quiles MR, Mar\u00edn LA, Muro M, Guerra N, Parrado A, Campos M, Fr\u00edas JF, Minguela A, Garc\u00eda-Alonso AM, \u00c1lvarez-L\u00f3pez MR (2006b) Natural killer receptors on CD8 T cells and Naural Killer cells from different HLA-C phenotypes in melanoma patients. Clin Cancer Res 12:4822\u20134831","journal-title":"Clin Cancer Res"},{"key":"682_CR9","doi-asserted-by":"crossref","first-page":"e8132","DOI":"10.1371\/journal.pone.0008132","volume":"4","author":"P Carrega","year":"2009","unstructured":"Carrega P, Pezzino G, Queirolo P, Bonaccorsi I, Falco M, Vita G, Pende D, Misefari A, Moretta A, Mingari MC, Moretta L, Ferlazzo G (2009) Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells. PLoS One 4:e8132","journal-title":"PLoS One"},{"key":"682_CR10","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00262-005-0682-5","volume":"54","author":"JG Casado","year":"2005","unstructured":"Casado JG, Soto R, De la Rosa O, Peralbo E, del Carmen M-VM, Rioja L, Pe\u00f1a J, Solana R, Tarazona R (2005) CD8 T-cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype. Cancer Immunol Immunother 54:1162\u20131171","journal-title":"Cancer Immunol Immunother"},{"key":"682_CR11","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00262-009-0682-y","volume":"58","author":"JG Casado","year":"2009","unstructured":"Casado JG, Pawelec G, Morgado S, Sanchez-Correa B, Delgado E, Gayoso I, Duran E, Solana R, Tarazona R (2009) Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines. Cancer Immunol Immunother 58:1517\u20131526","journal-title":"Cancer Immunol Immunother"},{"key":"682_CR12","doi-asserted-by":"crossref","first-page":"854","DOI":"10.4049\/jimmunol.179.2.854","volume":"179","author":"JH Chewning","year":"2007","unstructured":"Chewning JH, Gudme CN, Hsu KC, Selvakumar A, Dupont B (2007) KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J Immunol 179:854\u2013868","journal-title":"J Immunol"},{"key":"682_CR13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1399-0039.2002.600401.x","volume":"60","author":"S Chouaib","year":"2002","unstructured":"Chouaib S, Thiery J, Gati A, Gerra N, El Behi M, Doroth\u00e9e G, Mami-Chouaib F, Bellet B, Caignard A (2002) Tumor escape from killing: Role of killer inhibitory receptors and acquisition of tumor resistance to cell death. Tissue Antigens 60:273\u2013281","journal-title":"Tissue Antigens"},{"key":"682_CR14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nri1919","volume":"6","author":"AJ Cochran","year":"2006","unstructured":"Cochran AJ, Huang R-R, Lee J, Itakura E, Leong SP, Essner R (2006) Tumour induced immune modulation of sentinel lymph nodes. Nat Rev Immunol 6:659\u2013670","journal-title":"Nat Rev Immunol"},{"key":"682_CR15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2009.12.009","volume":"135","author":"C Cognet","year":"2010","unstructured":"Cognet C, Farnarier C, Gauthier, Frassati C, Andr\u00e9 P, Mag\u00e9rus-Chatinet A, Anfossi N, Rieux-Laucat F, Vivier E, Schleinitz N (2010) Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells. Clin Immunol 135:26\u201332","journal-title":"Clin Immunol"},{"key":"682_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00251-006-0168-4","volume":"59","author":"Z Du","year":"2007","unstructured":"Du Z, Gjertson DW, Reed EF, Rajalingam R (2007) Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics 59:1\u201315","journal-title":"Immunogenetics"},{"key":"682_CR17","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood-2009-09-245746","volume":"115","author":"C Fauriat","year":"2010","unstructured":"Fauriat C, Ivarsson MA, Ljunggren H-G, Malmberg K-J, Micha\u00eblsson J (2010) Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 115:1166\u20131174","journal-title":"Blood"},{"key":"682_CR18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood-2008-01-132902","volume":"112","author":"BA Foley","year":"2008","unstructured":"Foley BA, De Santis D, Van Beelen E, Lathbury LJ, Christiansen FT, Witt CS (2008) The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations. Blood 112:435\u2013443","journal-title":"Blood"},{"key":"682_CR19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-5699(96)10075-X","volume":"18","author":"F Garrido","year":"1997","unstructured":"Garrido F, Ruiz-Cabello F, Cabrera T, Perez-Villar JJ, Lopez-Botet M, Duggan-Keen M, Stern PL (1997) Implications for immunosurveillance of altered HLA class I phenotypes in human tumors. Immunol Today 18:89\u201395","journal-title":"Immunol Today"},{"key":"682_CR20","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1084\/jem.20091010","volume":"206","author":"T Graef","year":"2009","unstructured":"Graef T, Moesta AK, Norman PJ, Abi-Rached L, Vago L, Older Aguilar AM, Gleimer M, Hammond JA, Guethlein LA, Bushnell DA, Robinson PJ, Parham P (2009) KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med 206:2557\u20132572","journal-title":"J Exp Med"},{"key":"682_CR21","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/eji.200425089","volume":"34","author":"P Hansasuta","year":"2004","unstructured":"Hansasuta P, Dong T, Thananchai H, Weekes M, Willber C, Aldemir H, Rowland-Jones S, Braud VM (2004) Recognition of HLA-A3 and HLA-11 by KIR3DL2 is peptide-specific. Eur J Immunol 34:1673\u20131679","journal-title":"Eur J Immunol"},{"key":"682_CR22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00251-012-0629-x","volume":"64","author":"JA Hollenbach","year":"2012","unstructured":"Hollenbach JA, Nocedal I, Ladner MB, Single RM, Trachtenberg EA (2012) Killer cell immunoglobulin-like receptor (KIR) gene content variation in the HGDP-CEPH populations. Immunogenetics 64:719\u2013737","journal-title":"Immunogenetics"},{"key":"682_CR23","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.4049\/jimmunol.173.3.1819","volume":"173","author":"G Katz","year":"2004","unstructured":"Katz G, Gazit R, Arnon TI, Gonen-Gross T, Tarcic G, Markel G, Gruda R, Achdout H, Drize O, Merims S, Mandelboim O (2004) MHC class I-independent recognition of NK-activating receptor KIR2DS4. J Immunol 173:1819\u20131825","journal-title":"J Immunol"},{"key":"682_CR24","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/hep.23477","volume":"51","author":"S Knapp","year":"2010","unstructured":"Knapp S, Warshow U, Hegazy D, Brackenbury L, Guha IN, Fowell A, Little AM, Alexander GJ, Rosenberg WM, Cramp ME, Khakoo SI (2010) Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology 51:1168\u20131175","journal-title":"Hepatology"},{"key":"682_CR25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/13547500902814658","volume":"14","author":"G Konjevic","year":"2009","unstructured":"Konjevic G, Mirjacic Martinovic K, Jurisic V, Babovic N, Spuzic I (2009) Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells. Biormarkers 14:258\u2013270","journal-title":"Biormarkers"},{"key":"682_CR26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00262-007-0436-7","volume":"57","author":"P Larrieu","year":"2008","unstructured":"Larrieu P, Renaud V, Godet Y, Jotereau F, Fonteneau JF (2008) A HLA-Cw*0701 restricted melan-A\/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes. Cancer Immunol Immunother 57:745\u2013752","journal-title":"Cancer Immunol Immunother"},{"key":"682_CR27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/9525","volume":"5","author":"PP Lee","year":"1999","unstructured":"Lee PP, Yee C, Savage PA, Fong L, Brokstedt D, Weber J, Johnson D, Swetter S, Thompson J, Greenberg PD, Roederer M, Davis MM (1999) Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 5:677\u2013685","journal-title":"Nat Med"},{"key":"682_CR28","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1167\/iovs.08-2733","volume":"50","author":"W Maat","year":"2009","unstructured":"Maat W, Van der Slik AR, Verhoeven DH, Alizadeh DZ, Ly LV, Verduijn W, Luyten GP, Mulder A, van Hall T, Koning F, Jager MJ, van Bergen J (2009) Evidence for Natural killer cell-mediated protection from metastasis formation in uveal melanoma patients. Investig Ophthalmol Vis Sci 50:2888\u20132895","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"682_CR29","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1084\/jem.184.3.913","volume":"184","author":"O Mandelboim","year":"1996","unstructured":"Mandelboim O, Reyburn HT, Val\u00e9s-G\u00f3mez M, Pazmany L, Colonna M, Borsellino G, Strominger JL (1996) Protection from lysis by Natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med 184:913\u2013922","journal-title":"J Exp Med"},{"key":"682_CR30","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/sj.bjc.6690405","volume":"80","author":"A Martayan","year":"1999","unstructured":"Martayan A, Fraioli R, Giorda E, Setini A, Ciccarelli G, Delfino L, Ferrara GB, Giacomini P (1999) Biosynthesis of HLA-C heavy chains in melanoma cells with multiple defects in the expression of HLA-A, -B, -C molecules. Br J Cancer 80:639\u2013649","journal-title":"Br J Cancer"},{"key":"682_CR31","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00251-010-0477-5","volume":"62","author":"MP Martin","year":"2010","unstructured":"Martin MP, Borecki IB, Zhang Z, Nguyen L, Ma D, Gao X, Qi Y, Carrington M, Rader JS (2010) HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer. Immunogenetics 62:761\u2013765","journal-title":"Immunogenetics"},{"key":"682_CR32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2567.2009.03208.x","volume":"129","author":"D Middleton","year":"2010","unstructured":"Middleton D, Gonzelez F (2010) The extensive polymorphism of KIR genes. Immunology 129:8\u201319","journal-title":"Immunology"},{"key":"682_CR33","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.4049\/jimmunol.180.6.3969","volume":"180","author":"AK Moesta","year":"2008","unstructured":"Moesta AK, Norman PJ, Yawata M, Yawata N, Gleimer M, Parham P (2008) Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J Immunol 180:3969\u20133979","journal-title":"J Immunol"},{"key":"682_CR34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","volume":"19","author":"A Moreta","year":"2001","unstructured":"Moreta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L (2001) Activating receptors and co-receptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197\u2013223","journal-title":"Annu Rev Immunol"},{"key":"682_CR35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.smim.2006.03.002","volume":"18","author":"L Moretta","year":"2006","unstructured":"Moretta L, Bottino C, Pende D, Castriconi R, Mingari MC, Moretta A (2006) Surface NK receptors and their ligands on tumor cells. Semin Immunol 18:151\u2013158","journal-title":"Semin Immunol"},{"key":"682_CR36","first-page":"339","volume":"11","author":"R Nasca","year":"1999","unstructured":"Nasca R, Carbone E (1999) Natural killer cells as potential tools in melanoma metastatic spread control. Oncol Res 11:339\u2013343","journal-title":"Oncol Res"},{"key":"682_CR37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00262-006-0151-9","volume":"56","author":"E Naumova","year":"2007","unstructured":"Naumova E, Mihaylova A, Milena I, Mihailova S (2007) Impact of KIR\/HLA ligand combinations on immune responses in malignant melanoma. Cancer Immunol Immunother 56:95\u2013100","journal-title":"Cancer Immunol Immunother"},{"key":"682_CR38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00262-004-0575-z","volume":"54","author":"E Naumova","year":"2005","unstructured":"Naumova E, Mihaylova A, Stoitchkov K, Ivanova M, Quin L, Toneva M (2005) Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Cancer Immunol Immunother 54:172\u2013178","journal-title":"Cancer Immunol Immunother"},{"key":"682_CR39","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1102025","volume":"305","author":"P Parham","year":"2004","unstructured":"Parham P (2004) NK cells lose their inhibition. Science 305:786\u2013787","journal-title":"Science"},{"key":"682_CR40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","volume":"5","author":"P Parham","year":"2005","unstructured":"Parham P (2005) MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5:201\u2013214","journal-title":"Nat Rev Immunol"},{"key":"682_CR41","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2384::AID-IMMU2384>3.0.CO;2-L","volume":"28","author":"D Pende","year":"1998","unstructured":"Pende D, Accame L, Pareti L, Mazzocchi A, Moretta A, Parmiani G, Moretta L (1998) The susceptibility to natural killer cell-mediated lysis of HLA class-I positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles. Eur J Immunol 28:2384\u20132394","journal-title":"Eur J Immunol"},{"key":"682_CR42","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1182\/blood-2008-06-164103","volume":"113","author":"D Pende","year":"2009","unstructured":"Pende D, Marcenaro S, Falco M, Martini S, Bernardo ME, Montagna D, Romeo E, Cognet C, Martinetti M, Maccario R, Mingari MC, Vivier E, Moretta L, Locatelli F, Moretta A (2009) Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 113:3119\u20133129","journal-title":"Blood"},{"key":"682_CR43","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.4049\/jimmunol.180.5.2767","volume":"180","author":"N Remtoula","year":"2008","unstructured":"Remtoula N, Bensussan A, Marie-Cardine A (2008) Cutting Edge: Selective expression of inhibitory or activating killer cell Ig-like receptors in circulating CD4+ T lymphocytes. J Immunol 180:2767\u20132771","journal-title":"J Immunol"},{"key":"682_CR44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1744-313X.2011.01024.x","volume":"38","author":"N Tajik","year":"2011","unstructured":"Tajik N, Shahsavar F, Poormoghim H, Radjabzadeh MF, Mousavi T, Jalali A (2011) KIR3DL1\u2009+\u2009HLA-B Bw4Ile80 and KIR2DS1\u2009+\u2009HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population. Int J Immunogenet 38:403\u2013409","journal-title":"Int J Immunogenet"},{"key":"682_CR45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.coi.2012.01.001","volume":"24","author":"A Thielens","year":"2012","unstructured":"Thielens A, Vivier E, Romagn\u00e9 F (2012) NK cells MHC class I specific receptors (KIR) from biology to clinical intervention. Curr Opin Immunol 24:239\u2013245","journal-title":"Curr Opin Immunol"},{"key":"682_CR46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/978-1-4613-8545-5_3","volume-title":"HLA and disease associations","author":"JL Tiwari","year":"1985","unstructured":"Tiwari JL, Terasaki PI (1985) The data and statistical analysis. In: Tiwary JL, Terasaki PI (eds) HLA and disease associations. Springer, New York, p 18"},{"key":"682_CR47","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJMoa1200503","volume":"367","author":"JM Venstrom","year":"2012","unstructured":"Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E, Dupont B, Hsu KC (2012) HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. N Engl J Med 367:805\u2013816","journal-title":"N Engl J Med"},{"key":"682_CR48","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00262-008-0601-7","volume":"58","author":"S Verheyden","year":"2009","unstructured":"Verheyden S, Ferrone S, Mulder A, Claas FH, Schots R, De Moerloose B, Benoit Y, Demanet C (2009) Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by natural killer cells. Cancer Immunol Immunother 58:855\u2013865","journal-title":"Cancer Immunol Immunother"},{"key":"682_CR49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1399-0039.2007.00923.x","volume":"70","author":"C Vilches","year":"2007","unstructured":"Vilches C, Casta\u00f1o J, G\u00f3mez-Lozano N, Estefania E (2007) Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. Tissue Antigens 70:415\u2013422","journal-title":"Tissue Antigens"},{"key":"682_CR50","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1002\/cncr.23955","volume":"113","author":"MA Warycha","year":"2008","unstructured":"Warycha MA, Christos PJ, Mazumdar M, Darvishian F, Shapiro RL, Berman RS, Pavlick AC, Kopf AW, Polsky D, Osman I (2008) Changes in the presentation of nodular and superficial spreading melanomas over 35\u00a0years. Cancer 113:3341\u20133348","journal-title":"Cancer"}],"container-title":["Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-013-0682-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00251-013-0682-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-013-0682-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T01:46:48Z","timestamp":1688003208000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00251-013-0682-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1007\/s00251-013-0682-0","relation":{},"ISSN":["0093-7711","1432-1211"],"issn-type":[{"value":"0093-7711","type":"print"},{"value":"1432-1211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]}}}